CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net (loss) income	$ (20,658)	$ 33,280
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation and amortization	2,396	2,372
Benefit from deferred income taxes	(10,640)	(9,139)
Share-based compensation expense	14,159	18,069
Unrealized loss on equity investments with readily determinable fair value and warrants	11,471	9,969
Other non-cash adjustments	3,652	3,136
Change in assets and liabilities:
Accounts receivable, net	(76,263)	(36,704)
Net related party receivables	3,106	(7,221)
Prepaid expenses and other assets	(15,270)	(49,252)
Investments	(1,963)	(2,067)
Accounts payable	(2,949)	(3,190)
Net related party payables	(195)	(563)
Accrued and other liabilities	87,795	47,831
Deferred revenue	16,816	(51,625)
Operating lease right-of-use assets and lease liabilities	30,427	28,884
Net cash provided by (used in) operating activities	41,884	(16,220)
Cash flows from investing activities:
Capital expenditures	(3,248)	(1,084)
Purchases of investments	(2,101)	(4,605)
Net cash used in investing activities	(5,349)	(5,689)
Cash flows from financing activities:
Dividends paid	(633)	(682)
Taxes paid in lieu of shares issued for equity-based compensation	(11,773)	(8,084)
Proceeds from revolving credit facilities	0	75,000
Repayment of revolving credit facilities	(8,000)	(40,000)
Repayment of NHL advance	(6,000)	0
Net cash (used in) provided by financing activities	(26,406)	26,234
Net increase in cash, cash equivalents and restricted cash	10,129	4,325
Cash, cash equivalents and restricted cash at beginning of period	94,907	40,459
Cash, cash equivalents and restricted cash at end of period	105,036	44,784
Non-cash investing and financing activities:
Capital expenditures incurred but not yet paid	$ 22	$ 105